Table 1.
Characteristics | n | (%) |
---|---|---|
Age (mean±SD) | 32.54±13.9 | |
Male | 44 | (46.3) |
Duration of illness (days) (mean±SD) | 78.80±54.8 | |
History of tuberculosis | 24 | (25.3) |
BMRC staging | ||
I | 21 | (22.1) |
II | 41 | (43.2) |
III | 33 | (34.7) |
Fever | 92 | (96.8) |
Headache severity | ||
Mild | 22 | (23.2) |
Moderate | 22 | (23.2) |
Severe | 35 | (36.8) |
Headache severity | ||
Mild | 22 | (23.2) |
Moderate | 22 | (23.2) |
Severe | 35 | (36.8) |
Headache severity | ||
Mild | 22 | (23.2) |
Moderate | 22 | (23.2) |
Severe | 35 | (36.8) |
Intolerable | 16 | (16.8) |
Vomiting | 76 | (80.0) |
Seizures | 44 | (46.3) |
Diplopia | 38 | (40.0) |
Cranial nerve involvement | 52 | (54.7) |
Hemiparesis | 7 | (7.4) |
Papilledema | 55 | (57.9) |
Optic atrophy | 16 | (16.8) |
Ataxia | 7 | (7.4) |
Paraparesis | 5 | (5.3) |
Vision | ||
Normal | 84 | (88.4) |
Low vision | 7 | (7.4) |
Blindness | 4 | (4.2) |
Neck rigidity | 73 | (76.8) |
Kerning sign | 74 | (77.9) |
AFB stain positive | 23 | (24.2) |
Culture positive | 14 | (14.7) |
PCR positive | 51 | (52.7) |
Diagnostic category | ||
Definite | 53 | (55.8) |
Probable | 22 | (23.2) |
Possible | 20 | (21.0) |
MRI findings | ||
Exudates | 38 | (40.0) |
Meningeal enhancement | 42 | (44.2) |
Hydrocephalus | 42 | (44.2) |
Tuberculoma | 35 | (36.8) |
Infarct | 13 | (13.7) |
Normal | 14 | (14.7) |
Follow up at 6 months | ||
Death | 15 | (15.8) |
Good outcome (MBI >12) | 72 | (75.8) |
Poor outcome (MBI ≤12) | 8 | (8.4) |
BMRC - British Medical Research Council, MBI - Modified Barthel index, AFB - acid-fast bacillus, PCR - polymerase chain reaction